Neurotech Names Ted Danse as New President and CEO
Neurotech, a biotechnology company specializing in the development of sight-saving innovative therapeutics for chronic retinal diseases, announced the appointment of Ted Danse as its new President and Chief Executive Officer.
Mr. Danse has over 25 years of life science experience, including more than 20 years in the ophthalmic industry. Previously he served as President and CEO of the US ophthalmic pharmaceutical company ISTA Pharmaceuticals Inc. where he was responsible for taking the company public in 2000. He has also served as a Director on the boards of two development-stage ophthalmic companies, Quest Vision Technologies, Inc. and Vision Solutions Technologies, Inc. His early career was spent in business development roles at Coopervision, Bausch & Lomb and Schering-Plough. He then went on to hold various senior positions in Allergan. Mr. Danse holds a BA degree from the University of the Pacific, California, USA and an MBA from Thunderbird, The Garvin Graduate School of International Management, Arizona, USA.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
